Home

Kevin Koch, President and CEO: Edgewise Therapeutics EWTX Sell · Filed 25/08/14

Trade details

Type
Insider sale
Amount
$106,745.08
Shares · price
7,972 sh · $13.39 a share
Held after
30,615 sh
Trade date
25/08/12
Filed
25/08/14
Days to filing
2 days

Sold 20.7% of holdings

Share of holding sold
20.7%

Edgewise Therapeutics trades, last 26 weeks

What else happened in Edgewise Therapeutics around then

Filed or reported within 30 days of the trade day · 25/07/13~25/09/11

Kevin Koch's recent trades

  • Kevin Koch

    SellEdgewise Therapeutics

    $70.3K

    Filed 25/05/07

  • Kevin Koch

    Sell10b5-1 planEdgewise Therapeutics

    $3,000

    Filed 25/03/11

  • Kevin Koch

    Sell10b5-1 planEdgewise Therapeutics

    $259.3K

    Filed 25/02/07

  • Kevin Koch

    Sell10b5-1 planEdgewise Therapeutics

    $28K

    Filed 25/02/07

  • Koch Kevin

    Planned sale10b5-1 planEdgewise Therapeutics

    $1.5M

    Filed 25/02/05

Kevin Koch, CEO — sold $106.7K of Edgewise Therapeutics EWTX · 20.7% of holdings | Whalegun